Early Bird Pricing:
ANCO Professional Members: $35
Physician: $50
Nurse/Nurse Practitioner/Physician Assistant: $25
Resident/Fellow: $15
Industry: $300
After January 8th Pricing
ANCO Professional Members: $50
Physician: $75
Nurse/Nurse Practitioner/Physician Assistant: $35
Resident/Fellow: $25
Industry: $350
This Program Was Organized In Collaboration with Association of Northern California Oncologies
Special Discounted Rates are Available For Members
Program Overview
Breast cancer research continues to advance scientific and clinical knowledge of the disease and bring new techniques, treatments, and strategies to practicing clinicians. As such, clinicians need to stay current with best practices and clinical updates in prevention, screening, diagnosis, and treatment of breast cancer. Understanding results from recent clinical trials and key topics in breast cancer will help clinicians optimize management of patients with breast cancer and ultimately improve patient outcomes.
Learning Objectives
After participating in the Best of SABCS®️ program, learners will be able to:
1. UPDATE knowledge on the rapidly evolving landscape of breast cancer management to optimize patient care and outcomes.
2. APPLY current evidence on biomarker-driven diagnostics and subtype-specific treatments to optimize therapeutic decision-making for patients for people with breast cancer.
3. CONSTRUCT risk - and response-adapted management strategies for diverse patient populations to minimize unnecessary toxicity while optimizing outcomes.
4. INTEGRATE new cancer therapy research into clinical practice, with particular attention to sequencing, combinations, and toxicity management.
Target Audience
This official Best of SABCS program is directed to practicing oncologists (medical, surgical, radiation), community physicians, medical residents and fellows training in oncology, as well as other pertinent healthcare professionals involved in oncology medicine.
Tentative Agenda
| 7:30 AM - 8:30 AM | Registration, Continental Breakfast and Visit with Exhibitors | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8:30 AM - 8:45 AM | Welcome and Introduction of Program and Faculty Pre-Knowledge Assessment | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8:45 AM - 9:15 AM | New Directions in Breast Cancer Survivorship and Approaches to Risk Reduction | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9:15 AM - 9:45 AM | Insights in Translational Research and Resistance Mechanisms | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9:45 AM - 10:15 AM | Biomarker Discoveries and Molecular Signatures | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10:15 AM - 10:30 AM | Panel Questions and Answers session | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10:30 AM - 10:45 AM | Refreshment Break with Exhibitors | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10:45 AM - 11:15 AM | Updates in HR+ Disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11:15 AM - 11:45 PM | Advances in Approaches to Local-regional disease (surgical and radiation) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11:45 AM - 12:00 PM | Panel Questions and Answers session | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12:00 PM - 1:00 PM | Lunch Break and Supported Symposium – Exhibits Open | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1:00 PM - 1:30 PM | Updates in HER2+ Disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1:30 PM - 2:00 PM | Updates in TNBC | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2:00 PM - 2:30 PM | Panel Questions and Answers Session and Clinical Controversies and Case Studies | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2:30 PM - 2:45 PM | Wrap-up and Post Test | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2:45 PM | Adjournment | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint-providership of the University of Texas at San Antonio and Encore Medical Education, LLC.
The University of Texas at San Antonio is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This activity has been approved for AMA PRA Category 1 Credits™.
Partnership Opportunities
www.bestofsabcs.com/partnerships